A/s Novo, 10% Owner at CoLucid Pharmaceuticals, Inc. (CLCD), bought 3,056,563 shares at $10.00 ($13.0M) on 2015-05-11, disclosed to the SEC on 2015-05-12.
Open-market purchase of $13.0M CLCD by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,756,563 | $0 | 0.0% |
| 2 | $10.00 | 1,300,000 | $13.0M | 100.0% |
| Total | $4.25 avg | 3,056,563 | $13.0M | 100% |
| Filing → |
| RETA | SELL | 2017-06-12 | $5.7M | — | Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $590K | — | Filing → |